Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.235 USD | +1.23% | +2.44% | -16.00% |
Apr. 09 | Transcript : Immunic, Inc. - Special Call | |
Mar. 21 | Immunic Gets US Patent Notice of Allowance For Specific Polymorph of Vidofludimus Calcium | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.00% | 110M | |
-2.87% | 103B | |
+1.41% | 95.28B | |
+1.46% | 22.15B | |
-15.99% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.25% | 16.05B | |
+4.87% | 13.68B | |
+33.17% | 12.17B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic Says Phase 2 Trial Further Reinforces Vidofludimus Calcium's Neuroprotective Potential; Shares Rise After Hours